3.5000
-0.2700
(-7.16%)
At close: January 10 at 4:00:01 PM EST
3.4617
-0.04
(-1.09%)
After hours: January 10 at 4:11:03 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-95,088.0000
11,919.0000
-179,871.0000
-74,799.0000
-36,697.0000
Investing Cash Flow
31,599.0000
92,053.0000
-238,988.0000
-46,406.0000
-151.0000
Financing Cash Flow
468.0000
3,543.0000
431,789.0000
158,506.0000
46,823.0000
End Cash Position
72,956.0000
170,920.0000
63,245.0000
50,380.0000
13,066.0000
Income Tax Paid Supplemental Data
1,675.0000
6,389.0000
27.0000
--
--
Capital Expenditure
-493.0000
-1,241.0000
-2,526.0000
-353.0000
-151.0000
Issuance of Capital Stock
201,106.0000
--
432,447.0000
135,000.0000
29,958.0000
Issuance of Debt
--
--
--
26,159.0000
16,817.0000
Repayment of Debt
--
--
--
-263.0000
--
Free Cash Flow
-95,581.0000
10,678.0000
-182,397.0000
-75,152.0000
-36,848.0000
12/31/2020 - 1/7/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
VTYX Ventyx Biosciences, Inc.
2.0800
-7.56%
SLRN Acelyrin, Inc.
2.0600
-3.74%
RPTX Repare Therapeutics Inc.
1.3800
+7.81%
INZY Inozyme Pharma, Inc.
1.9950
-28.75%
FDMT 4D Molecular Therapeutics, Inc.
5.52
-5.48%
STOK Stoke Therapeutics, Inc.
9.00
+0.45%
XLO Xilio Therapeutics, Inc.
1.1000
-1.79%
CLYM Climb Bio, Inc.
2.0000
+6.95%
IGMS IGM Biosciences, Inc.
2.0900
-66.29%
DNLI Denali Therapeutics Inc.
19.10
-10.12%